← FDA DRUG APPROVALS

FDA ANDA · ANDA208127

TRIMIPRAMINE

Sponsor: BRECKENRIDGE

APPLICATION
ANDA208127
TYPE
ANDA
ORIGINAL APPROVAL
2016-04-15
LATEST ACTION
2025-11-03
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

TRIMIPRAMINE MALEATEPrescription
TRIMIPRAMINE MALEATE EQ 100MG BASE · CAPSULE · ORAL
TRIMIPRAMINE MALEATEPrescription
TRIMIPRAMINE MALEATE EQ 25MG BASE · CAPSULE · ORAL
TRIMIPRAMINE MALEATEPrescription
TRIMIPRAMINE MALEATE EQ 50MG BASE · CAPSULE · ORAL

Approval history

2025-11-03Manufacturing (CMC) · Supplement 5 · standardAP
2016-04-15UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →